Does early α-fetoprotein response predict survival in patients with advanced hepatocellular carcinoma treated with sorafenib?
Early AFP response may be useful for predicting survival in patients with advanced HCC treated with sorafenib.
MAC appeared to independently influence the immediate result of PTMC; therefore, mitral annulus evaluation may be considered in the echocardiographic assessment of the mitral apparatus prior to PTMC.